Live
- Medical devices sector needs separate rules, says industry body AiMeD
- Opposition INDIA bloc working on 'one year, one PM' formula: PM Modi
- Delhi HC quashes FIR for outraging woman's modesty, orders man to assist Traffic Police for a month as settlement
- 'Apologise to families of farmers who committed suicide in Vidarbha', Amit Shah dares Sharad Pawar
- SC Collegium recommends appointment of a permanent judge in Chhattisgarh HC, extension of term of two judges
- U20 Men's football nationals: Telangana, Sikkim earn full points with easy win
- SEBI probes 2 funds for shorting Adani stocks before Hindenburg
- Kerala Governor Arif Mohammed Khan visits Prashanti Nilayam
- All people should Co-operate for free and fair elections
- "Audiences in the South will appreciate a story that smashes the stereotype of weak and meek women," says Yatin Karyekar
Suven Life bags 2 patents
Suven Life bags 2 patents. Suven Life Sciences Ltd on Friday said it secured one patent each from Mexico and Singapore.
.jpg)
Hyderabad: Suven Life Sciences Ltd on Friday said it secured one patent each from Mexico and Singapore. These patents correspond to the new chemical entities (NCEs) used for the treatment of disorders associated with neurodegenerative diseases, and are valid through 2029.
“The granted claims of the patents include the class of selective alpha-4-beta-2 compounds discovered by Suven and are being developed as therapeutic agents for major depressive disorder (MDD),” the company said.
With these new patents, Suven has a total of 18 granted patents from Mexico and 20 granted patents from Singapore. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts.
Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II. "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for Major Depressive Disorder (MDD) with high unmet medical need with huge market potential globally,”said Venkat Jasti, CEO, Suven.
